The influence of nicergoline on cerebral, systemic and cardiac hemodynamics in patients who have had an ischemic stroke

  • Victor Kuznetsov D. F. Chebotarev Institute of Gerontology, Kyiv, Ukraine
Keywords: ischemic stroke; rehabilitation; nicergoline; hemispheric localization; hemodynamics


The Aim of study was analysis of the effect of nicergoline on the cerebral, cardiac, systemic hemodynamics of patients after ischemic stroke, taking into account the hemispheric localization of the ischemic focus. Materials and methods. A comprehensive clinical and neurological examination was carried out in 38 elderly patients (mean age 64.3 ± 2.5 years) who had undergone atherothrombotic ischemic stroke in the carotid system (recovery period). There were 20 patients with left hemispheric stroke and 18 with right hemispheric stroke. All patients had arterial hypertension (AH). These were ACE inhibitors (enalapril 10-20 mg 1 tablet 2 times a day) and hydrochlorothiazide at a dose of 12.5 mg. Patients received nicergoline at a dose of 4 mg IV drip for 10 days. A comprehensive examination was carried out before and after treatment with nicergoline. The Results of the study allowed us to conclude that the course of nicergoline intake in patients after ischemic atherothrombotic stroke improves the subjective state and reduces the severity of neurological disorders, cerebral hemodynamics, increases linear systolic blood flow velocities (LBFVsys) and reduces peripheral resistance in individual extra- and intracranial vessels of the carotid and vertebro-basilar basins. In patients with right and left hemispheric localization of stroke under the influence of nicergoline, LBFVsys increases in the right and left ICA, PCA, and VA. In addition, LBFVsys increases in patients with right hemispheric stroke in the right MBA; in patients with left hemisphere - in two MBA and BA. In ischemic stroke patients, nicergoline affects systemic and cardiac hemodynamics: it reduces the systemic and cardiac hemodynamics, decreases the systemic vascular resistance and increases the ejection fraction, changes the structure of the relationship between systemic and cerebral hemodynamics, forming a positive relationship between blood pressure and hemodynamics in the vessels of the vertebro-basilar basin. Thus, the complex positive effect of nicergoline on various levels of cerebral, systemic and cardiac hemodynamics in ischemic stroke patients gives grounds to recommend the inclusion of this drug in the rehabilitation system of this category of patients.

Author Biography

Victor Kuznetsov, D. F. Chebotarev Institute of Gerontology, Kyiv, Ukraine

DSc (Medicine), Leading Researcher of Department of Vascular Pathology of the Brain, Department of Rehabilitation of Neurological Patients



Kadykov, A.S.; Chernikova, L.A.; Shakhparonova, N.V. Rehabilitation of neurological patients (in Russian). Medpress-inform: Mocow, 2009, p 560

Windish, M. Drugs that enhance cognitive functions (nootropics) (in Russian). EBEVE: Mocow, 2001, p 23. doi: 10.3233/JAD-121729

Cattabeni, F. Protein kinase C in synaptic plasticity: A molecular target in the treatment of cognitive disorders. Dement Geriat Cogn Dis 1997, 8,1, pp. 6-11

Winblad, B.; Fioravanti, M.; Dolezal, T.; Logina, I.; Gospodinov, I. et al. Therapeutic use of nicergoline. Clin Drug Invest 2008, 28, pp. 533-552. doi:10.2165/00044011-200828090-00001

Zylberman, M.R.; Fontana, M.; Dolce, G. Effects of nicergoline on learning, mood and behaviour in hemiplegic patients undergoing rehabilitation. Ergot alkaloids and aging brain: an update on nicergoline. Ed. Kugler, J.; Agnoli, A. Excerpta Medica: Amsterdam, 1988, pp. 57-63

Loganovsky, K.N.; Yuriev, K.L. Pharmacological properties and therapeutic potential of Sermion. Neuropsychiatric effects of Sermion (in Russian). Ukr. Med. Magazine 2005, 2, 46, pp. 59-75.

Ogawa, N.; Asanuma, M.; Hirata, H.; Kondo, Y.; Kawada, Y. et al. Cholinergic deficits in aged rat brain are corrected with nicergoline. Arch Gerontol Geriatr 1993, 16, pp. 103-110.

Calza, L.; Giardino, L. Neuroprotection: a realistic goal for aged brain? Adv Exp Med Biol 2004,541, pp. 153-168. doi: 10.1007/978-1-4419-8969-7_9

Moretti, A.; Carfagna, N.; Caccia, C.; Carpentieri, M. et al. Effect of ergolines on neurotransmitter systems in the rat brain. Arch Int Pharmacodyn Ther 1988, 294, pp. 33-45.

Odinak, M.M.; Emelin, A.Yu.; Lobzin, V.Yu. Cognitive impairment in cerebrovascular pathology (in Russian). VMedA: St. Petersburg, 2006, p 158

Caraci, F.; Chisari, M.; Frasca, G.; Canonico, P.L.; Battaglia, A. et al. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity. Brain Res 2005, 1047, pp. 30-37. doi: 10.1016/j.brainres.2005.04.004

Rudenko, G.M.; Muzychenko, A.P. Results of a clinical study of the drug Sermion (analysis of data from the pharmacological committee) (in Russian). Moscow, 1987, p 31.

Яхно Н.Н., Захаров В.В., Локшина А.Б. и др. Деменции. Руководство для врачей. 2-е изд. М: МЕДпресс-информ 2010; 272. Yakhno, N.N.; Zakharov, V.V.; Lokshina, A.B. et al. Dementia. A guide for doctors. 2nd ed. (in Russian). MEDpress-inform: Moscow, 2010, p 272

Crook, T.H. Nicergoline: Parallel evolution of clinical trial methodology and drug development in dementia. Dement Geriat Cogn Dis 1997, 8, 1, pp. 22-26. doi: 10.1159/000106667

Suslina, Z.A. Essays on angioneurology (in Russian). Atmosphere: Moscow, 2005, pp. 108-121

Pyshkina, L.I.; Fedin, A.I. The use of vasoactive drugs for occlusive lesions of the main arteries of the head (in Russian). Abstracts of the VII All-Russian Congress of Neurologists: N. Novgorod,1995, p. 287

Sorokina, T.A.; Shafro, I.S.; Krievane, D.A. The state of cerebral circulation in older patients with coronary artery disease (in Russian). Ischemic heart and brain disease, mental illness in geriatric practice (abstracts): Irkutsk, 1990, pp. 115-117

Ena, L.M.; Egorova, M.S. Features of Holter ECG monitoring in elderly and senile patients with cardioembolic stroke (in Russian). Archives of Clinical and Experimental Medicine 2009, 2, pp. 227-230

Spasennikov, B.A. Dyscirculatory encephalopathy (pathogenetic, clinical and pharmacological aspects). Abstract of the dissertation (in Russian). RSMU: Moscow 1996, p.278

Kuznetsova S.M., Slivak E.A., Prikhodko V.Yu. (1999) The effect of serion on cerebral hemodynamics in elderly patients with residual symptoms of ischemic acute cerebrovascular accident in the carotid system (in Russian). Ukr. Med. Magazine 1999, 5,13, pp. 18-21

How to Cite
Kuznetsov, V. (2021). The influence of nicergoline on cerebral, systemic and cardiac hemodynamics in patients who have had an ischemic stroke. Ageing and Longevity, 2(1), 32-41. Retrieved from